ACT Brief: Zip Code Trial Access, Smaller Biotech APAC Perceptions, and Pimjetmi Tumor Approval

0:00-1:30

In today’s ACT Brief, we examine how ZIP code shapes trial availability and enrollment, why smaller biotechs hold outdated views of APAC sites, and how FDA approved Pimjetmi for symptomatic tenosynovial giant cell tumor.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8976517

Published

November 13, 2026

Duration

2 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#zipcodetrial #smallerbiotechapac #pimjetmitumorapproval #lifesciences

The Nile